Wormax 10 Flavour 3 Tablets

PHARMACOTHERAPEUTIC CATEGORY:  Anthelmintics - Praziquantel, combinations.

COMPOSITION:

One 624 mg tablet contains: active ingredients; praziquantel 50 mg, fenbendazole 500 mg.

Excipients:  Polyvinylpyrrolidone, magnesium stearate, sodium lauryl sulfate, croscarmellose sodium, meat flavor.

 INDICATIONS:

Indicated in dogs and cats for the control and treatment of infections by nematodes and tapeworms; in particular the mature and immature forms of the following parasites. Ascarids: toxocara canis, toxascaris leonina; hookworms: ancylostoma caninum, uncinaria stenocephala, ancylostoma tubaeforme; whipworms: trichuris vulpis; tapeworms: echinococcusgranulosus, e.multilocularis, dipylidium caninum, taenia spp, multiceps multiceps, mesocestoides spp. In dogs indicated for the treatment of protozoan infections: Giardia spp.

CONTRAINDICATIONS/SIDE EFFECTS:

Do not administer the product during the first 4 weeks of pregnancy. Do not use in animals with known hypersensitivity to the active ingredients or to any of the excipients.

Animals treated with high doses, cats in particular, may experience episodes of vomiting and diarrhea. However, the symptoms remit spontaneously. The frequency of adverse reactions is defined using the following conventions:very common (more than 1 in 10 animals treated shows adverse reactions); common (more than 1 but less than 10 animals in 100 animals treated); uncommon (more than 1 but less than 10 animals in 1,000 animals treated); rare (more than 1 but less than 10 animals in 10,000 animals treated); very rare (less than 1 in 10,000 animals treated, including isolated reports).

PHARMACEUTICAL FORM: Tablets

USE/ROUTE OF ADMINISTRATION:

For oral use.

DOSAGE:

To ensure To administer the correct dose, body weight should be determined as accurately as possible. The recommended dose is 5 mg/kg praziquantel and 50 mg/kg fenbendazole equivalent to 1 tablet per 10 kg of live weight. Indicative dosage: DOGS Puppies and small dogs. Dog weight (kg): 1/2 - 2 kg b.w.; 1/4 tablet. Dog weight (kg): 2 - 5 kg b.w.; 1/2 tablet. Dog weight (kg): 5 - 10 kg b.w.; 1 tablet. CATS. Kittens: 1/4 tablet; Adult cats up to 5 kg: 1/2 tablet; Adult cats over 5 kg: 1 tablet. Administer the tablet directly into the mouth or, if necessary, mix it with the preferred food. Always check that the medicine has actually been taken. In the case of severe infections, repeat the treatment after 24 hours. No purging or fasting or other special measures are necessary to ensure the effectiveness of the product. For the treatment of Giardia spp in dogs, administer for three consecutive days.

STORAGE:

Do not store above 25 degrees C. Store the blister in the original packaging to protect it from light and humidity.

WARNINGS:

Care should be taken to avoid the following practices as they may increase the risk of resistance development and may ultimately result in ineffective therapy: too frequent and repeated use of anthelmintics of the same class over a prolonged period of time; under-dosing, due to incorrect body weight estimation, failure to administer the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be verified using appropriate tests (e.g. Faecal Egg Reduction Test). When test results confirm resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Selection of major resistance genes leading to the development of resistance may lead to ineffective anthelmintic therapy. Special precautions for use in animals. Do not administer the product during the first 4 weeks of pregnancy. Special precautions to be taken by the person administering the veterinary medicinal product to animals. Wash hands after use. Avoid contact with eyes. In case of eye irritation, seek medical advice. Do not eat, drink or smoke while using the product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label. To avoid contamination, destroy any faeces expelled within 24 hours of treatment. Other precautions: the veterinary medicinal product is effective against Echinococcus spp. which is not present in all European countries but is becoming increasingly common. Echinococcosis represents a danger for humans. Considering that echinococcosis is a disease known to the World Organisation for Animal Health (OIE), specific guidelines on treatment and control, and on the protection of people, must be provided by the relevant competent authorities. In case of overdose (doses up to 5 times higher than those recommended), episodes of vomiting and diarrhoea which regress spontaneously may occur, especially in cats.

SAFETY IN TARGET SPECIES:

In case of overdose,(doses up to 5 times higher than those recommended), episodes of vomiting and diarrhea that regress spontaneously may occur, especially in cats.

TARGET SPECIES:

Dogs and Cats

INTERACTIONS:

Do not administer at the same time as piperazine derivatives.

DIAGNOSIS AND PRESCRIPTION:

Veterinary medicine without prescription.

PREGNANCY AND BREASTFEEDING:

Do not administer during the first 4 weeks of pregnancy.